Insulin ‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme
ConclusionAcross the entire left ventricular EF spectrum in the EMPEROR Programme, concentrations of the senescence-associated biomarker IGFBP7 were associated with higher risk clinical status and predicted adverse cardio-renal outcomes even in models adjusted for conventional biomarkers. Empagliflozin did not significantly affect IGFBP7 levels over time.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Jo ão Pedro Ferreira,
Milton Packer,
Naveed Sattar,
Javed Butler,
Sandra González Maldonado,
Marina Panova‐Noeva,
Mikhail Sumin,
Serge Masson,
Stuart J. Pocock,
Stefan D. Anker,
Faiez Zannad,
James L. Januzzi Tags: Research Article Source Type: research
More News: Cardiology | Cardiovascular | Empagliflozin | Heart | Heart Failure | Insulin | Jardiance | Study